Effect of γ-butyrobetaine on fatty liver in juvenile visceral steatosis mice
Authors:
- 1 April 2001
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 53 (4) , 527-533
Abstract
We pharmacokinetically examined the effect of γ-butyrobetaine, a precursor of l-carnitine, on the change of fatty acid metabolism in juvenile visceral steatosis (JVS) mice, which have systemic l-carnitine deficiency due to lack of l-carnitine transporter activity. The concentrations of total free fatty acid (FFA), palmitic acid and stearic acid in the liver of JVS mice were significantly higher than those in wild-type mice. After intravenous administration of γ-butyrobetaine (50 mg kg−1), the concentration of l-carnitine in the plasma of JVS mice reached about twice that of the control level and levels in the brain, liver and kidney were also significantly increased, whereas those in wild-type mice hardly changed. Although the plasma concentrations of FFA in both types of mice were unchanged after administration of γ-butyrobetaine, the concentrations of palmitic acid and stearic acid were significantly decreased. In particular, the liver concentration of FFA in JVS mice was decreased to the wild-type control level, accompanied by significant decreases in long-chain fatty acids, palmitic acid and stearic acid, whereas those in wild-type mice were not changed. These results suggest that γ-butyrobetaine can be taken up into organs, including the liver, of JVS mice, and transformed to l-carnitine. Consequently, administration of γ-butyrobetaine may be more useful than that of l-carnitine itself for treatment of primary deficiency of carnitine due to a functional defect of the carnitine transporter.Keywords
This publication has 21 references indexed in Scilit:
- Characterization of a sodium-dependent transport system for butyrobetaine into rat liver plasma membrane vesiclesHepatology, 1998
- Secondary abnormality of carnitine biosynthesis results from carnitine reabsorptional system defect in juvenile visceral steatosis miceBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1997
- Effects of l-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the l-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) trialJACC, 1995
- Primary defect of juvenile visceral steatosis (jvs) mouse with systemic carnitine deficiency is probably in renal carnitine transport systemBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1994
- Animal model of systemic carnitine deficiency: Analysis in C3H-H-2° strain of mouse associated with juvenile visceral steatosisBiochemical and Biophysical Research Communications, 1991
- Carnitine deficiency syndromesPediatric Neurology, 1990
- Infantile disease with microvesicular fatty infiltration of viscera spontaneously occurring in the C3H-H-2° strain of mouse with similarities to Reye's syndromeLaboratory Animals, 1988
- Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome.Journal of Clinical Investigation, 1985
- Effects of carnitine on acetyl-CoA oxidation by heart muscle mitochondriaAmerican Journal of Physiology-Legacy Content, 1964
- Carnitine in Intermediary MetabolismJournal of Biological Chemistry, 1962